Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer

Fig. 1

Characterization of Ptb-M-Lip-Her. A TEM images of Lip and Ptb-M-Lip-Her. B Particle size distribution of Lip, M-Lip, Ptb-M-Lip and Ptb-M-Lip-Her obtained by DLS. C Zeta potential of Lip, M-Lip, Ptb-M-Lip and Ptb-M-Lip-Her. D 7-day stability test of Ptb-M-Lip-Her. E Cumulative release curve of Ptb in Ptb-M-Lip-Her. F SDS-PAGE analysis of SK-BR-3 cell membrane, Ptb-M-Lip and Ptb-M-Lip-Her. G Western blot analysis (N-cadherin, Galectin-3, EpCAM) of SK-BR-3 cell membrane, Ptb-M-Lip and Ptb-M-Lip-Her. H Western blot analysis (EGFR, ErBb2) of SK-BR-3 cell membrane, Ptb-M-Lip and Ptb-M-Lip-Her. All data represent mean ± SD (n = 3)

Back to article page